NCT04446104View on ClinicalTrials.gov

A Preventive Treatment for Migrant Workers at High-risk of COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

4,257

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Covid-19
Interventions
DRUG

Hydroxychloroquine Sulfate Tablets

Hydroxychloroquine tablet 400mg loading dose, followed by 200mg daily for 42 days

DRUG

Ivermectin 3mg Tab

Ivermectin tablet 12mg single dose

DRUG

Zinc

Zinc tablet 80 mg/vitamin C 500mg daily for 42 days

DRUG

Povidone-Iodine

Povidone-iodine throat spray (3 times daily) for 42 days

DIETARY_SUPPLEMENT

Vitamin C

Vitamin C tablet 500mg daily for 42 days

Trial Locations (1)

Unknown

Tuas South Dormitory, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT04446104 - A Preventive Treatment for Migrant Workers at High-risk of COVID-19 | Biotech Hunter | Biotech Hunter